← Back to Clinical Trials
Recruiting NCT07786233

NCT07786233 Multi-Field-Strength MRI Brain Atlas Construction in Healthy Chinese Population

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07786233
Status Recruiting
Phase
Sponsor Tang-Du Hospital
Condition Healthy Adult Brain Imaging
Study Type INTERVENTIONAL
Enrollment 500 participants
Start Date 2026-07-01
Primary Completion 2027-07-01

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age 66 Years
Study Type INTERVENTIONAL
Interventions
Multi-Field-Strength Brain MRI

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 500 participants in total. It began in 2026-07-01 with a primary completion date of 2027-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective imaging study aims to construct a multi-field-strength magnetic resonance imaging (MRI) brain atlas for healthy Chinese adults. Healthy volunteers will undergo standardized brain MRI examinations at multiple magnetic field strengths, including 0.55T, 1.5T, 3T, 5T, and 7T. Structural, diffusion, functional, and other quantitative MRI data will be acquired and analyzed. The study will characterize the consistency and differences in brain morphology and imaging measurements across field strengths and establish standardized multi-field-strength brain templates and reference data for healthy Chinese adults.

Eligibility Criteria

Inclusion Criteria: * Aged 16 to 66 years. Voluntarily participates in the study and provides written informed consent. No contraindications to MRI examination and able to cooperate with and complete the MRI examinations. Female participants must not be pregnant. No current or previous clinical diagnosis of severe neurological or psychiatric disorders, such as schizophrenia, dementia, epilepsy, or severe sequelae of traumatic brain injury. No obvious intracranial lesions or structural abnormalities identified on routine MRI examination. Exclusion Criteria: * Presence of contraindications to MRI examination, including MRI-incompatible implanted metallic or electronic devices, cochlear implants, cardiac pacemakers, intracranial metallic clips, or similar devices. Severe claustrophobia preventing completion of the MRI examination. Pregnancy. Current or previous clinical diagnosis of severe neurological or psychiatric disorders. History of severe head trauma, brain tumor, stroke, brain surgery, or other conditions that may substantially affect brain structure or function. MRI data of insufficient quality for analysis due to marked discomfort, excessive head motion, or other causes during the examination.

Contact & Investigator

Central Contact

Ziheng Zhou

✉ 173416171@qq.com

📞 +86 18710574531

Frequently Asked Questions

Who can join the NCT07786233 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, up to 66 Years, studying Healthy Adult Brain Imaging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07786233 currently recruiting?

Yes, NCT07786233 is actively recruiting participants. Contact the research team at 173416171@qq.com for enrollment information.

Where is the NCT07786233 trial being conducted?

This trial is being conducted at Xi'an, China.

Who is sponsoring the NCT07786233 clinical trial?

NCT07786233 is sponsored by Tang-Du Hospital. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology